Clinical Trial Update: Pretreatment Botulinum Toxin in Head and Neck Cancer Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pretreatment botulinum toxin in head and neck cancer surgery. The study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Sir Mortimer B. Davis - Jewish General Hospital | Conditions: Head Neck Cancer, Xerostomia Following Radiotherapy | Phase 2 | Status: NOT_YET_RECRUITING